logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Yoshihito Kogure

nho nagoya medical center
H指数:25
被引数:2,265

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Safety and Efficacy of Direct Cryobiopsy Specimen Retrieval Through the 3.0-mm Working Channel of a Therapeutic Bronchoscope Using a 1.1-mm Cryoprobe: A Multicentre Prospective Observational Study

通过治疗性支气管镜3.0-mm工作通道使用1.1-mm冷冻探头直接获取冷冻活检标本的安全性和有效性：一项多中心前瞻性观察研究

Respirology
IF6.3
2026-09-170
OAAI
Yuki Takigawa; Masahide Oki; Ken Sato; Suzuka Matsuoka; Atsushi Torii; Jun Nishimura; Yuka Shinohara; Hiromi Watanabe; Masahiro Sano; Kenichiro Kudo; Akiko Sato; Yoshihito Kogure; Keiichi Fujiwara; Takuo Shibayama
Efficacy and safety of first-line lenvatinib in patients with advanced or recurrent thymic carcinoma in the real-world setting

真实世界中，一线乐伐替尼治疗晚期或复发性胸腺癌的疗效与安全性研究

Lung Cancer
IF4.4
2026-02-070
OAAI
Ryosuke Tsugitomi; Kento Takagi; Go Saito; Motoko Tachihara; Hironori Ashinuma; Takehito Shukuya; Shinnosuke Takemoto; Shinya Sakata; Atsuto Mouri; Hideki Miwa; Yosuke Tamura; Takaaki Tokito; Yoko Tsukita; Yoshihito Kogure; Takeshi Masuda; Hiroshi Tanaka; Sousuke Kubo; Takaaki Sasaki; Tomohiro Oba; Nobuaki Mamesaya
Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study

帕博利珠单抗联合培美曲塞在PD-L1表达状态不同的老年非鳞状NSCLC患者中的疗效：CJLSG1901研究的结果

Cancer Treatment and Research Communications
IF2.4
2026-01-010
OAAI
Kogure, Yoshihito; Hashimoto, Hiroya; Ikeda, Satoshi; Harada, Toshiyuki; Hino, Aoi; Miura, Satoru; Goto, Yasuhiro; Fujiwara, Keiichi; Katakami, Nobuyuki; Kubota, Kaoru; Murata, Naohiko; Mori, Masahide; Abe, Takashi; Saito, Akiko M.; Yamamoto, Nobuyuki; Saka, Hideo; Kondo, Masashi
Radiotherapy-free pembrolizumab combined with chemotherapy for locally advanced non-small-cell lung cancer with PD-L1 tumour proportion score of 50% or higher (Evolution trial): a multicentre, single-arm, phase 2 study

无放疗的帕博利珠单抗联合化疗治疗PD-L1肿瘤比例评分≥50%的局部晚期非小细胞肺癌（Evolution试验）：一项多中心、单臂、Ⅱ期研究

The Lancet Oncology
IF0
2025-10-110
PRE
Akito Hata; Taira Ninomaru; Hideaki Okada; Yoshihito Kogure; Masahide Oki; Nobuyuki Katakami; Takashi Kijima; Toshihide Yokoyama; Hirotaka Matsumoto; Yuki Sato; Terufumi Kato; Shunichi Sugawara; Takeshi Sawada; Kenichi Yoshimura; Takashi Seto; Kazuhiko Nakagawa; Isamu Okamoto; Nobuyuki Yamamoto
Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer
SCIENTIFIC REPORTS
IF3.9
2023-03-063
OAAI
Fujimoto, Daichi; Miura, Satoru; Tomii, Keisuke; Sumikawa, Hiromitsu; Yoshimura, Kenichi; Wakuda, Kazushige; Oya, Yuko; Yokoyama, Toshihide; Kijima, Takashi; Asao, Tetsuhiko; Tamiya, Motohiro; Nakamura, Atsushi; Yoshioka, Hiroshige; Tokito, Takaaki; Murakami, Shuji; Tamiya, Akihiro; Yokouchi, Hiroshi; Watanabe, Satoshi; Yamaguchi, Ou; Morinaga, Ryotaro; Jodai, Takayuki; Ito, Kentaro; Shiraishi, Yoshimasa; Kogure, Yoshihito; Shibaki, Ryota; Yamamoto, Nobuyuki

研究方向

暂未获取到该数据
H
Hideo Saka
H 指数:48论文数:378被引数:1.3万
C
Chiyoe Kitagawa
H 指数:24论文数:204被引数:2,494
M
Masahide Oki
H 指数:20论文数:172被引数:1,447
M
Masahide Oki
H 指数:18论文数:115被引数:1,230
M
Masahiko Ando
H 指数:29论文数:225被引数:3,773
N
Nobuyuki Yamamoto
H 指数:73论文数:1,055被引数:2.9万
A
Atsushi Torii
H 指数:7论文数:34被引数:154
A
Arisa Yamada
H 指数:8论文数:49被引数:214
H
Hiroya Hashimoto
H 指数:13论文数:111被引数:709
M
Masashi Nakahata
H 指数:6论文数:37被引数:245